Overview

Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find if Rituximab can improve severe ocular lesions of Behcet's Disease.
Phase:
Phase 2
Details
Lead Sponsor:
Tehran University of Medical Sciences
Collaborator:
Hoffmann-La Roche
Treatments:
Rituximab